Brainsway Ltd. ADR (BWAY)
Market Closed
30 Jul, 20:00
NASDAQ (NMS) NASDAQ (NMS) Primary $
15. 25
+1.09
+7.6977%
$
598.15M Market Cap
- P/E Ratio
- Div Yield
81,348 Volume
-0.03 Eps
$ 14.16
Previous Close 
Want to track BWAY and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
BrainsWay Ltd. (BWAY) Q2 2024 Earnings Call Transcript
BrainsWay Ltd. (NASDAQ:BWAY ) Q2 2024 Earnings Call Transcript August 6, 2024 8:30 AM ET Company Participants Brian Ritchie - IR, LifeSci Advisors Hadar Levy - CEO Ido Marom - CFO Conference Call Participants Steve Lichtman - Oppenheimer Jeffery S.
Seekingalpha | 1 year ago
Strength Seen in Brainsway (BWAY): Can Its 9.3% Jump Turn into More Strength?
Brainsway (BWAY) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock doesn't suggest further strength down the road.
Zacks | 2 years ago
BrainsWay (BWAY) Inks Distribution Agreement to Expand Foothold
BrainsWay's (BWAY) latest exclusive multi-year distribution agreement is likely to provide improved patient care in Canada.
Zacks | 2 years ago
BrainsWay (BWAY) to Advance in DEEP TMS for MDD With New Trial
BrainsWay (BWAY) emphasizes the potential of the accelerated protocol, citing previous data suggesting comparable outcomes with traditional, longer protocols.
Zacks | 2 years ago
